Norbert G. Riedel, Director at Jazz Pharmaceuticals plc (JAZZ), sold 801 shares at $183.36 ($144K) on 2015-08-10, disclosed to the SEC on 2015-08-11.
Open-market sale of $144k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.98 | 797 | $143K | 99.5% |
| 2 | $183.36 | 4 | $733 | 0.5% |
| Total | $180.00 avg | 801 | $144K | 100% |
| Filing → |
| JAZZ | SELL | 2022-08-09 | $1.6M | — | Filing → |
| APTX | BUY | 2021-12-08 | $223K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |